Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)
SIMPLE SUMMARY: Acute promyelocytic leukemia (APL) currently benefits from first-line treatment based on all-trans retinoic acid and arsenic trioxide, ensuring long-term complete responses for most patients. However, a proportion of 5–20% of patients relapse, and their long-term survival, even in th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452822/ https://www.ncbi.nlm.nih.gov/pubmed/37627139 http://dx.doi.org/10.3390/cancers15164111 |